2025
SJR Q1
JCR Q2 · 2,4
OA
25 matched articles
ESCI
Journal detail
SICOT-J
- Publisher
- EDP Sciences
- Country
- France · Western Europe
- Type
- journal
- ISSN
-
24268887
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,786
- Quartile Q1
- H-Index 33
- Cites/doc 2,59
- Docs (3y) 137
- Cites (3y) 338
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,4
- 5Y JIF 2,6
- JCI 0,89
WoS indexes
- ESCI
Subject classification
Categories (SJR)
- Orthopedics and Sports Medicine Q2
- Surgery Q1
Areas
- Medicine
WoS categories
- Orthopedics
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 0,786 | 2,4 | 2,6 | 0,89 | Q2 | 33 |
| 2024 | Q1 | Q2 | 0,737 | 2,3 | 2,3 | 0,81 | Q2 | 30 |
| 2023 | Q1 | Q2 | 0,751 | 1,8 | 2,1 | 0,7 | Q3 | 30 |
| 2022 | Q2 | — | 0,634 | 1,6 | 2,3 | 0,65 | Q3 | 30 |
| 2021 | Q2 | — | 0,521 | — | — | 0,7 | Q2 | 30 |
| 2020 | Q2 | — | 0,596 | — | — | 0,66 | Q2 | 30 |
| 2019 | — | — | — | — | — | — | — | 30 |
| 2017 | — | — | — | — | — | — | — | 30 |
| 2016 | — | — | — | — | — | — | — | 30 |
| 2015 | — | — | — | — | — | — | — | 30 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ORTHOPEDICS | ESCI | Q2 | Q2 | 53/147 |
| 2024 | ORTHOPEDICS | ESCI | Q2 | Q2 | 46/140 |
| 2023 | ORTHOPEDICS | ESCI | Q2 | Q3 | 61/136 |
| 2022 | ORTHOPEDICS | ESCI | — | Q3 | — |
| 2021 | ORTHOPEDICS | ESCI | — | Q2 | — |
| 2020 | ORTHOPEDICS | ESCI | — | Q2 | — |